# Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET)

> **NCT04720391** · — · UNKNOWN · sponsor: **European Institute of Oncology** · enrollment: 500 (estimated)

## Conditions studied

- Bone Metastases
- Neuroendocrine Neoplasm

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04720391
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-08
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04720391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04720391, "Bone Metastases in neurOendocrine NEoplasms: naTural History, Prognostic Impact and Therapeutic Approach (MONET)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04720391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*